# Retraction Note: MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer

**Authors:** Nana Li, Yuan Miao, Yujia Shan, Bing Liu, Yang Li, Lifen Zhao, Li Jia

PMC · DOI: 10.1038/s41419-026-08631-2 · Cell Death & Disease · 2026-03-20

## Full-text entities

- **Genes:** MIR9-3 (microRNA 9-3) [NCBI Gene 407051] {aka MIRN9-3, hsa-mir-9-3, miRNA9-3, mir-9-3}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MIR106B (microRNA 106b) [NCBI Gene 406900] {aka MIRN106B, mir-106b}
- **Diseases:** breast cancer (MESH:D001943)
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13004991/full.md

---
Source: https://tomesphere.com/paper/PMC13004991